✦ LIBER ✦

Combination Treatment with Irritant and Recombinant Interleukin 2 in the Peritoneal Cavity for Evoking Effective Anti-tumor Activity: Generation of Lymphokine-activated Killer Cells and Tumor-specific Killer Cells

✍ Scribed by Uchida, Hiroyuki ;Taniguchi, Kazuto ;Nomoto, Kikuo

Book ID: 108579068
Publisher: Wiley (Blackwell Publishing)
Year: 1990
Tongue: English
Weight: 549 KB
Volume: 81
Category: Article
ISSN: 0910-5050
DOI: 10.1111/j.1349-7006.1990.tb02584.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vivo anti-tumor activity of combinati

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

✍ Michael J. Brunda; Donna Bellantoni; Viveca Sulich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 684 KB

The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met

Enhanced local dendritic cell activity a

Enhanced local dendritic cell activity and tumor-specific immunoresponse in combined radiofrequency ablation and interleukin-2 for the treatment of human head and neck cancer in a murine orthotopic model

✍ Koichiro Saito; Koji Araki; Nishant Reddy; Wei Guang; Bert W. O'Malley Jr; Daqin 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract ## Background. Radiofrequency ablation (RFA) is a minimally invasive tumor destruction technique and can provide the antigen source initiating tumor immunity. However, induced immune response is weak and requires additional immunotherapy for optimized RFA treatment against cancer. ##